With critical meetings of the European Central Bank and the U.S. Federal Reserve scheduled to take place during the first half of September, stock-market volatility is bound to increase. Read More

Smartphones are becoming ubiquitous devices around the globe, with plenty of room left for growth. Here are the best plays now in this fast-growing niche. Read More

With the majority of energy-focused master limited partnerships (MLP) having reported quarterly results, we have an opportunity to reflect one of the key trends that emerged from the deluge of financial data: the extent to which the dramatic decline in the price of natural gas liquids reduced firms’ distributable cash flow (DCF) and payout coverage. Read More

Investors who depend on dividends for retirement income are anxious about the election’s impact on dividend stocks. However, fears that dividend-paying stocks could suffer a massive selloff are overblown. Read More

U.S. energy royalty trusts have been great income investments over the past decade, but buying high yields at prices above underlying asset value can be dangerous to your wealth. Read More

Safety and stability are complemented nicely by solid dividend growth, as Canada's Big Six banks post good numbers and spread their wealth to shareholders. Read More

Stable, high-dividend stocks with direct investment plans, or DRIPs, are an income investor’s best friend. Here’s a roundup of the cream of the crop. Read More

The war on obesity is starting to heat up. Here are two stocks that will cash in as more Americans look to cut their waistlines.   Read More

Investing Daily's investment experts share some intimate details about their investment firsts and what lessons they learned. Read More

Gilead Sciences (NasdaqGS: GILD) may lead the race to offer an all-oral treatment for Hepatitis C liver disease, but several other drug companies are also in the hunt. Read More